Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 09:04 am Sale | 2021-12-31 | 13G | Apollo Strategic Growth Capital APSG | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,214,200 2.710% | -3,641,400 (-62.19%) | Filing History |
| 2022-02-10 09:03 am Sale | 2021-12-31 | 13G | ECP Environmental Growth Opportunities Corp. ENNV | ADAGE CAPITAL PARTNERS GP L.L.C. | 849,300 2.460% | -1,150,100 (-57.52%) | Filing History |
| 2022-02-10 09:03 am Purchase | 2021-12-31 | 13G | Amalgamated Financial Corp. AMAL | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,743,427 5.610% | 1,743,427 (New Position) | Filing History |
| 2022-02-10 09:03 am Sale | 2021-12-31 | 13G | National Vision Holdings, Inc. EYE | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,220,332 5.100% | -3,647,211 (-46.36%) | Filing History |
| 2022-02-10 09:01 am Unchanged | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-10 09:01 am Sale | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ADAGE CAPITAL PARTNERS GP L.L.C. | 40,000 2.030% | -79,680 (-66.58%) | Filing History |
| 2022-02-10 08:59 am Purchase | 2021-12-31 | 13G | Deep Lake Capital Acquisition Corp. DLCA | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,944,469 9.390% | 1,944,469 (New Position) | Filing History |
| 2022-02-10 08:58 am Purchase | 2021-12-31 | 13G | Adit EdTech Acquisition Corp. ADEX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,500,000 4.350% | 1,500,000 (New Position) | Filing History |
| 2022-02-10 08:57 am Sale | 2021-12-31 | 13G | Arq, Inc. ARQ | ADAGE CAPITAL PARTNERS GP L.L.C. | 919,900 4.880% | -30,100 (-3.17%) | Filing History |
| 2022-02-10 08:56 am Unchanged | 2021-12-31 | 13G | Hyzon Motors Inc. HYZN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-10 08:56 am Purchase | 2021-12-31 | 13G | ArcLight Clean Transition Corp. II ACTD | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,313,400 4.220% | 1,313,400 (New Position) | Filing History |
| 2022-02-10 08:54 am Sale | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 899,997 1.470% | -1,350,003 (-60.00%) | Filing History |
| 2022-02-10 08:52 am Sale | 2021-12-31 | 13G | Abeona Therapeutics Inc. ABEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 320,291 5.460% | -11,229 (-3.39%) | Filing History |
| 2022-02-10 08:49 am Purchase | 2021-12-31 | 13G | Hennessy Capital Investment Corp. V HCIC | ADAGE CAPITAL PARTNERS GP L.L.C. | 75,000 0.220% | 75,000 (New Position) | Filing History |
| 2022-02-10 08:48 am Sale | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,509,500 (Position Closed) | Filing History |
| 2022-02-10 08:45 am Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 68,261 1.580% | 68,261 (New Position) | Filing History |
| 2022-02-07 5:37 pm Purchase | 2022-01-27 | 13G | TPG Pace Beneficial Finance Corp. TPGY | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,018,171 5.770% | 2,018,171 (New Position) | Filing History |
| 2022-01-21 4:47 pm Purchase | 2022-01-11 | 13G | CinCor Pharma, Inc. CINC | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,140,546 5.860% | 2,140,546 (New Position) | Filing History |
| 2022-01-18 4:30 pm Purchase | 2022-01-07 | 13G | CARTICA ACQ.CORP USD 1 SH CRTUF | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,800,000 7.830% | 1,800,000 (New Position) | Filing History |
| 2022-01-18 4:30 pm Purchase | 2022-01-05 | 13G | Ambrx Biopharma Inc. AMAM | ADAGE CAPITAL PARTNERS GP L.L.C. | 14,191,037 5.800% | 14,191,037 (New Position) | Filing History |